GET THE APP

Inhibition of reverse transcription of Infl uenza A virus genome | 840
Journal of Antivirals & Antiretrovirals

Journal of Antivirals & Antiretrovirals
Open Access

ISSN: 1948-5964

+44 1300 500008

Inhibition of reverse transcription of Infl uenza A virus genome RNA by peptide nucleic acids


International Conference and Exhibition on VIROLOGY

5-7 September 2011 Baltimore, USA

Kunihiro Kaihatsu and Nobuo Kato

Scientific Tracks Abstracts: JAA

Abstract :

Infl uenza A virus is a negative-strand RNA virus that possesses 8 genome segments in the virion. When the virus is exposed to low pH within the cellular endosome, it releases the viral RNP complex into the cellular cytoplasm. Determining whether nucleic acid analogues can recognize the viral RNA within the ribonucleoprotein (RNP) complex is important for development of infl uenza A diagnostic and treatment methods. We prepared phosphorothioate (PS) and peptide nucleic acid (PNA) that target a 15-base highly conserved sequence in the polymerase subunit 2 (PB2) genome and evaluated their abilities to recognize the RNP complex by monitoring the inhibition of reverse transcription using real-time RT-PCR. Both PS and PNA recognized the viral RNA within the RNP complex and inhibited the reverse transcription in a sequence-dependent manner. PNA had greater antiviral activity than PS. We also synthesized a series of PNAs that recognize diff erent types of the hemagglutinine genome sequences and succeeded to diagnose the virus strains. Further details will be discussed in this paper.

Biography :

Dr. Kunihiro Kaihatsu has completed his Ph. D at Kobe University, Japan, in 2001. He trained in organic chemistry, enzymatic chemistry, and nucleic acid chemistry in Japanese, American, and British institutions and is now Assistant Professor in the departments of organic fi ne chemicals at Osaka University in Osaka, Japan. He published numbers of papers in the fi eld of antisense technology between 2002 and 2005. His current research interests are in the development of antiviral agents, with emphasis on infl uenza viruses. He has won a jury?s special award in the 9th and 10th Biobusiness Competition Japan in 2009 and 2010.

Top